Novel breast cancer treatment leads to hyperglycaemia. [electronic resource]
Producer: 20210907Description: 893-894 p. digitalISSN:- 1464-5491
- Aged
- Antineoplastic Agents, Hormonal -- therapeutic use
- Blood Glucose -- metabolism
- Blood Glucose Self-Monitoring
- Breast Neoplasms -- complications
- Class I Phosphatidylinositol 3-Kinases -- genetics
- Female
- Fulvestrant -- therapeutic use
- Humans
- Hyperglycemia -- chemically induced
- Monitoring, Ambulatory
- Phosphoinositide-3 Kinase Inhibitors -- adverse effects
- Prediabetic State -- complications
- Thiazoles -- adverse effects
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.